Johnson & Johnson vaccine: EU regulator says blood clot ‘very rare side effect’

“One plausible explanation for the combination of blood clots and low blood platelets is an immune response, leading to a condition similar to one seen sometimes in patients treated with heparin called heparin induced thrombocytopenia, HIT,” it said.


Source link

Total
0
Shares
Related Posts

Sign Up for Our Newsletters

Get notified about major events on our website.